JP3187502B2 - Enteric granules - Google Patents

Enteric granules

Info

Publication number
JP3187502B2
JP3187502B2 JP02186292A JP2186292A JP3187502B2 JP 3187502 B2 JP3187502 B2 JP 3187502B2 JP 02186292 A JP02186292 A JP 02186292A JP 2186292 A JP2186292 A JP 2186292A JP 3187502 B2 JP3187502 B2 JP 3187502B2
Authority
JP
Japan
Prior art keywords
zein
layer
wheat
rice
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP02186292A
Other languages
Japanese (ja)
Other versions
JPH05186335A (en
Inventor
繁 樋崎
政明 山内
Original Assignee
カネボウ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カネボウ株式会社 filed Critical カネボウ株式会社
Priority to JP02186292A priority Critical patent/JP3187502B2/en
Publication of JPH05186335A publication Critical patent/JPH05186335A/en
Application granted granted Critical
Publication of JP3187502B2 publication Critical patent/JP3187502B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、胃液中においては難溶
性であるが、腸液中においては溶解性に優れた造粒物に
係り、更に詳しくは、口から摂取した後、胃では溶解せ
ず、腸管において初めて溶解し、腸管で乳酸菌生菌体等
の生理活性物質を多量に溶出し得る腸溶性造粒物に関す
るものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to granules which are sparingly soluble in gastric juice but have high solubility in intestinal fluid. The present invention relates to an enteric granulated substance which dissolves in the intestinal tract for the first time and can elute a large amount of a physiologically active substance such as live lactic acid bacteria in the intestinal tract.

【0002】[0002]

【従来の技術】近年、体内において、腸内細菌叢の有益
菌とされているビフィズス菌、一般乳酸菌等を増加さ
せ、有害菌とされている大腸菌、バクテロイデス菌等の
増殖を抑制し、常在性細菌叢を改善することにより、消
化器系の種々の疾患の予防、治療を行うことが試みられ
ている。上記有益菌を増加させる方法としては、これら
を含有する飲食物や錠剤を摂取する方法が挙げられる。
2. Description of the Related Art In recent years, bifidobacteria and general lactic acid bacteria, which are beneficial bacteria of the intestinal flora, have been increased in the body, and the growth of harmful bacteria such as Escherichia coli and Bacteroides has been suppressed. It has been attempted to prevent and treat various diseases of the digestive system by improving the sexual flora. As a method of increasing the beneficial bacteria, there is a method of ingesting food or drink or a tablet containing them.

【0003】しかしながら、ビフィズス菌や乳酸菌は、
pH4.5以上、嫌気性、36〜42℃の条件で培養さ
れるものであり、特に、pH4.2以下、溶存酸素の存
在、45℃以上の高温においては急激に死滅する。従っ
て、ビフィズス菌や乳酸菌を単にそのまま口から直接摂
取すると、胃液(pH1.0〜1.5、HCl 0.2
〜0.5重量%(以下、%と記す))によって死滅し、
腸管内での利用効率が著しく損なわれる。
[0003] However, bifidobacteria and lactic acid bacteria are
It is cultivated under conditions of pH 4.5 or more, anaerobic, 36 to 42 ° C., and rapidly dies when the pH is 4.2 or less, in the presence of dissolved oxygen, and at a high temperature of 45 ° C. or more. Therefore, when bifidobacteria and lactic acid bacteria are simply ingested directly from the mouth, gastric juice (pH 1.0-1.5, HCl 0.2
~ 0.5% by weight (hereinafter referred to as%))
The efficiency of use in the intestinal tract is significantly impaired.

【0004】従来、例えば、特開昭60−255731
号公報に記載されているようなビフィズス菌体顆粒の製
法が提案されている。この方法は、糖類、有機酸等の賦
形剤及び硬化油と共にビフィズス菌体を造粒することに
より、造粒時の圧力損傷を緩和し、ビフィズス菌体の生
残率を高める方法である。
Conventionally, for example, Japanese Unexamined Patent Publication No.
A method for producing bifidobacterium granules as described in Japanese Patent Application Laid-Open Publication No. H11-209,837 has been proposed. This method is a method of granulating bifidobacteria with excipients such as saccharides and organic acids and hardened oil, thereby reducing pressure damage during granulation and increasing the survival rate of bifidobacteria.

【0005】しかしながら、この方法においては、顆粒
中におけるビフィズス菌体の生残率は高まるものの、こ
の顆粒を人工胃液(pH1.2)で処理すると、ビフィ
ズス菌体は死滅する。したがって、口より上記顆粒を摂
取した場合、胃液によって相当数の菌体が死滅し、腸内
に生菌体のまま達する割合は少なくなる。また、このよ
うに造粒された菌体は、空気との接触面積が大きいの
で、菌体の活性を保持するための特別な保存方法が必要
である。
[0005] In this method, however, the survival rate of the bifidobacterium in the granules is increased, but when the granules are treated with artificial gastric juice (pH 1.2), the bifidobacteria are killed. Therefore, when the above granules are ingested from the mouth, a considerable number of cells are killed by gastric juice, and the ratio of living cells remaining in the intestine is reduced. In addition, since the cells thus granulated have a large contact area with air, a special preservation method for maintaining the activity of the cells is required.

【0006】前記欠点を解決する方法として、特開昭6
0−141281号公報に開示されている方法が挙げら
れる。この方法は、アルギン酸ナトリウム、澱粉等の保
護膜形成溶液と生菌体とを混合し、内径1mm以下の細
孔ノズルを用いて凝固液中に滴下し、凝固させ、乾燥し
た後、油脂でコーティングするものである。
As a method for solving the above-mentioned disadvantage, Japanese Patent Application Laid-Open No.
A method disclosed in Japanese Patent Application Publication No. 0-141281 is exemplified. In this method, a protective film-forming solution such as sodium alginate and starch is mixed with a viable cell, dropped into a coagulating liquid using a pore nozzle having an inner diameter of 1 mm or less, coagulated, dried, and then coated with an oil or fat. Is what you do.

【0007】しかしながら、この方法では、生菌体含有
溶液槽と、それを滴下するための細孔ノズルと、生菌体
含有溶液を凝固させるための凝固槽と、凝固した後洗
浄、回収乾燥させるための装置等特別な装置が必要であ
る。また、ノズル1回当りの滴下量が少ないために、生
産に長時間を要し、量産化しにくいという欠点がある。
However, in this method, a viable cell-containing solution tank, a pore nozzle for dropping the cell, a coagulation tank for coagulating the viable cell-containing solution, a coagulation, washing, recovery and drying. A special device such as a device for the above is required. In addition, since the amount of dripping per nozzle is small, there is a disadvantage that a long time is required for production and mass production is difficult.

【0008】[0008]

【発明が解決しようとする課題】本発明は、このような
事情に鑑みなされたものであって、その目的とするとこ
ろは、経口摂取した後、低pHの胃では溶解せず、腸管
において初めて溶解し、胃液のpHの影響を受けて、乳
酸菌生菌体等の生理活性物質が死滅等することなく、腸
管で多量に溶出し得、また、長期保存しても生理活性物
質の活性が低下することのない保存性安定な腸溶性造粒
物を提供するにある。
DISCLOSURE OF THE INVENTION The present invention has been made in view of such circumstances, and it is an object of the present invention to dissolve in a low-pH stomach after oral ingestion and to dissolve in the intestinal tract for the first time. Dissolves and is affected by the pH of gastric juice, so that a large amount of physiologically active substances such as living lactic acid bacteria can be eluted in the intestinal tract without dying, etc., and the activity of the physiologically active substances decreases even after long-term storage An object of the present invention is to provide a stable enteric granulated product which does not need to be stored.

【0009】[0009]

【課題を解決するための手段】上記の目的は、被造粒物
が下記(A)及び(B)に示される2層で被覆されてな
る腸溶性造粒物であって、該被造粒物が生理活性物質で
あり、かつ、(B)層に含有された小麦,大豆,米,コ
ラーゲン及びゼラチン由来の含水アルコール可溶性蛋白
質もしくはツェインの少なくとも1つを、腸溶性造粒物
全体重量中3重量%以上含有することを特徴とする腸溶
性造粒物によって達成される。 (A)小麦,大豆,米,コラーゲン及びゼラチン由来の
含水アルコール可溶性蛋白質もしくはツェインの少なく
とも1つ、油脂及び賦形剤含有層。 (B)小麦,大豆,米,コラーゲン及びゼラチン由来の
含水アルコール可溶性蛋白質もしくはツェインの少なく
とも1つを含有してなる層。
The purpose of the Means for Solving the Problems] is an enteric granules coated with two layers composed as shown in the granules is below (A) and (B), 該被granulation Things are biologically active substances
There, and wheat contained in the (B) layer, soybean, rice, co
Hydrous alcohol soluble protein from lagen and gelatin
This is achieved by an enteric granulate characterized in that at least one of the substance and the zein is contained in an amount of 3% by weight or more based on the total weight of the enteric granulate. (A) Derived from wheat, soy, rice, collagen and gelatin
Low in hydroalcohol soluble protein or zein
Both one fat and excipients containing organic layer. (B) from wheat, soy, rice, collagen and gelatin
Low in hydroalcohol soluble protein or zein
A layer containing both of them .

【0010】すなわち、本発明者らは、経口摂取した
後、胃液で溶解することなく、腸内消化液によって溶解
し、かつ、長期保存中に生理活性物質の活性低下を生じ
ない腸溶性造粒物について検討を行った。その結果、菌
体等の被造粒物を(A)小麦,大豆,米,コラーゲン及
びゼラチン由来の含水アルコール可溶性蛋白質もしくは
ツェインの少なくとも1つと油脂と賦形剤とを含有する
層(長期保存性安定化及び低pH域安定化層)と、
(B)小麦,大豆,米,コラーゲン及びゼラチン由来の
含水アルコール可溶性蛋白質もしくはツェインの少なく
とも1つ(低pH域安定化層)との2層よりなる造粒物
にすると、上記目的を達成する腸溶性造粒物となること
を見出し、本発明に到達した。
That is, the present inventors have found that after oral ingestion, enteric-coated granules which are not dissolved in gastric juice but dissolved in intestinal digestive juice and do not cause a decrease in the activity of physiologically active substances during long-term storage. The thing was examined. As a result, the granulated material such as cells was (A) wheat, soybeans, rice, collagen and
Hydrous alcohol-soluble protein derived from gelatin and gelatin or
Layer containing at least one and the oil and excipient zein and (long-term storage stabilization and low pH range stabilizing layer),
(B) from wheat, soy, rice, collagen and gelatin
Low in hydroalcohol soluble protein or zein
The present inventors have found that a granulated product composed of two layers, one of which is a low pH region stabilizing layer, is an enteric granulated product that achieves the above object, and the present invention has been achieved.

【0011】次に、本発明を詳しく説明する。本発明に
用いる被造粒物は、乳酸菌(好ましくは生菌数106
/g以上)、ビフィズス菌、酵母等経口摂取した後生体
内(特に腸管内)での利用性が高い微生物や、これらの
エキス、あるいはペプチド等の微生物増殖因子等、胃液
による影響を受けやすい各種生理活性物質である。上記
微生物は、凍結乾燥、減圧噴霧乾燥された菌体粉末を用
いるとよい。
Next, the present invention will be described in detail. Granules to be used in the present invention include lactic acid bacteria (preferably having a viable cell count of 10 6 / g or more), bifidobacteria, yeast, and other microorganisms having high availability in vivo (particularly in the intestinal tract) after oral ingestion, and the like. extract, or microbial growth factors such as peptides, Ru susceptible various physiologically active substance Shitsudea the influence of gastric juices. As the microorganism, freeze-dried and reduced pressure spray-dried cell powder may be used.

【0012】次に、上記被造粒物を被覆する2層のう
ち、造粒物を長期間にわたって安定化させると共に、低
pH域において安定化させるための(A)層には、
麦,大豆,米,コラーゲン及びゼラチン由来の含水アル
コール可溶性蛋白質もしくはツェインの少なくとも1つ
と油脂と賦形剤とが用いられる。
Next, among the two layers covering the granulated material, the layer (A) for stabilizing the granulated material for a long period of time and stabilizing in a low pH range includes a small layer.
Hydrous alcohol derived from wheat, soy, rice, collagen and gelatin
At least one of col soluble proteins or zein, fats and oils and excipients are used.

【0013】まず、油脂としては、ヤシ油、パーム油、
大豆油、菜種油、カカオ脂等の植物性油脂やそれらを硬
化させた硬化油等の固体脂やライスワックス、キャンデ
リラワックス、蜂蜜ろう等の食用ワックス等が挙げられ
る。これら油脂の融点は、被造粒物の生残性を阻害しな
い程度の低温域での均一分散性、展延性の点で30〜4
5℃が好ましい。
First, as fats and oils, coconut oil, palm oil,
Vegetable oils and fats such as soybean oil, rapeseed oil and cocoa butter, solid fats such as hardened oils obtained by hardening them, and edible waxes such as rice wax, candelilla wax and honey wax are included. The melting point of these fats and oils is 30 to 4 in terms of uniform dispersibility and spreadability in a low temperature range that does not impair the viability of the granulated material.
5 ° C. is preferred.

【0014】また、同じく(A)層に用いる賦形剤とし
ては、馬鈴薯、とうもろこし、米、麦等を原料とする澱
粉や卵、乳、穀類、豆類等を原料とする蛋白質やぶどう
糖、乳糖、蔗糖、麦芽糖等の糖類等が挙げられ、これら
は単独でも数種組合せて用いてもよい。
Similarly, excipients used in the layer (A) include starch, eggs, milk, cereals, beans and other proteins as raw materials such as potato, corn, rice and wheat, and glucose, lactose and the like. Saccharides such as sucrose and maltose may be mentioned, and these may be used alone or in combination of several kinds.

【0015】また、同じく(A)層には小麦,大豆,
米,コラーゲン及びゼラチン由来の含水アルコール可溶
性蛋白質もしくはツェインの少なくとも1つを含有す
る。これらは単独でも2種以上併用してもよい。また、
例えば、ツェインをアルカリ処理した後、アセトン抽出
をして得られる分子量5,000〜40,000のツェ
インペプチド等の分画物を用いたり、上記未処理ツェイ
ンとツェインペプチドとを併用してもよい。これらの中
でも、ツェインを用いると、より耐胃液性に優れ、好適
である。また、上記小麦,大豆,米,コラーゲン及びゼ
ラチン由来の含水アルコール可溶性蛋白質もしくはツェ
インの少なくとも1つに水溶性蛋白質を10重量%(以
下、%と記す)程度混合し、乾燥した乾燥物を用いても
よい。
Similarly, the layer (A) includes wheat, soybean,
Soluble with aqueous alcohol derived from rice, collagen and gelatin
Contains at least one of the sex protein or zein
You. These may be used alone or in combination of two or more. Also,
For example, a fraction such as a zein peptide having a molecular weight of 5,000 to 40,000 obtained by subjecting zein to an alkali treatment and then extracting with acetone may be used, or the untreated zein and the zein peptide may be used in combination. . Among them, the use of zein is more excellent in gastric juice resistance and is preferred. In addition, the above wheat, soybeans, rice, collagen and zeo
Hydrous alcohol-soluble protein or t
A dried product obtained by mixing about 10% by weight (hereinafter referred to as "%") of a water-soluble protein with at least one of the inks may be used.

【0016】本発明において、被造粒物を被覆すると
は、被造粒物隣接被覆層に、被造粒物が混在している場
合も含むものである。また、(A)層は、通常、油脂及
び賦形剤の混合物もしくは混融物中に、小麦,大豆,
米,コラーゲン及びゼラチン由来の含水アルコール可溶
性蛋白質もしくはツェインの少なくとも1つが混在した
状態となっている。ただし、上記3成分が各々ばらばら
で分散、混合した状態であってもよい。
In the present invention, covering the granulated material includes the case where the granulated material is mixed in the coating layer adjacent to the granulated material. Further, the layer (A) usually contains wheat, soybean,
Soluble with aqueous alcohol derived from rice, collagen and gelatin
At least one of the sex protein or zein . However, the three components may be dispersed and mixed separately.

【0017】次に、上記被造粒物を被覆する2層のう
ち、被造粒物を低pHで安定化させるための(B)層に
小麦,大豆,米,コラーゲン及びゼラチン由来の含水
アルコール可溶性蛋白質もしくはツェインの少なくとも
1つを含有させる小麦,大豆,米,コラーゲン及びゼ
ラチン由来の含水アルコール可溶性蛋白質もしくはツェ
インは、上記(A)層に用いられる小麦,大豆,米,コ
ラーゲン及びゼラチン由来の含水アルコール可溶性蛋白
質もしくはツェインと同様のものが使用できる。使用す
小麦,大豆,米,コラーゲン及びゼラチン由来の含水
アルコール可溶性蛋白質もしくはツェインは、単独でも
2種以上併用してもよく、また、(A)層と同じ小麦,
大豆,米,コラーゲン及びゼラチン由来の含水アルコー
ル可溶性蛋白質もしくはツェインを使用しても、別の
麦,大豆,米,コラーゲン及びゼラチン由来の含水アル
コール可溶性蛋白質もしくはツェインを使用してもよ
い。中でも、ツェインを用いると、より耐胃液性に優
れ、好適である。
Next, of the two layers covering the granulated material, the (B) layer for stabilizing the granulated material at a low pH includes a water-containing material derived from wheat, soybeans, rice, collagen and gelatin.
Alcohol soluble protein or zein
Contains one . Wheat, soybeans, rice, collagen and ze
Hydrous alcohol soluble protein or ts
Inn is the wheat, soybean, rice, cocoa used in the above (A) layer.
Hydrous alcohol soluble protein from lagen and gelatin
Similar to quality or zein can be used. Water content derived from wheat, soybeans, rice, collagen and gelatin used
The alcohol-soluble protein or zein may be used alone or in combination of two or more .
Hydrous alcohol derived from soybeans, rice, collagen and gelatin
It is used Le soluble protein or zein, another small
Hydrous alcohol derived from wheat, soy, rice, collagen and gelatin
Chole soluble protein or zein may be used. Among them, the use of zein is more excellent in gastric juice resistance and is preferred.

【0018】また、(B)層には、小麦,大豆,米,コ
ラーゲン及びゼラチン由来の含水アルコール可溶性蛋白
質もしくはツェインの均一溶解分解性を高めるために、
必要に応じて、可塑剤を用いるとよい。可塑剤として
は、グリセリン脂肪酸エステル、蔗糖脂肪酸エステル、
ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エス
テル等の乳化剤や、グリセリン、糖アルコール等が挙げ
られる。この中でも、特に、グリセリン脂肪酸エステル
小麦,大豆,米,コラーゲン及びゼラチン由来の含水
アルコール可溶性蛋白質もしくはツェインの均一溶解分
散性、及び被造粒物に被覆したときの均一被覆性の点で
好適である。可塑剤の添加量は、小麦,大豆,米,コラ
ーゲン及びゼラチン由来の含水アルコール可溶性蛋白質
もしくはツェインの量によっても異なるが、(B)層溶
液全体重量中の0.8%程度がよい。
The layer (B) includes wheat, soybeans, rice, and cocoa.
Hydrous alcohol soluble protein from lagen and gelatin
In order to enhance the uniform dissolution and decomposition of
If necessary, a plasticizer may be used. As the plasticizer, glycerin fatty acid ester, sucrose fatty acid ester,
Examples include emulsifiers such as polyglycerin fatty acid esters and sorbitan fatty acid esters, glycerin, sugar alcohols and the like. Among them, particularly, glycerin fatty acid esters are derived from wheat, soybeans, rice, collagen and gelatin.
It is suitable in terms of uniform dissolution and dispersibility of the alcohol-soluble protein or zein , and uniform coverage when coated on granules. The amount of plasticizer added is wheat, soy, rice,
Hydrous alcohol soluble protein derived from gen and gelatin
Alternatively, although it depends on the amount of zein , it is preferably about 0.8% of the total weight of the layer (B) solution.

【0019】上記(A)層及び(B)層の被造粒物への
被覆は、(A)層及び(B)層のどちらを先に被覆して
もよい。(A)層を先に被覆した後、(B)層を被覆し
た場合は、より耐胃液性に優れ、また、造粒物を製造す
る際の作業効率が良好である。逆に、(B)層を先に被
覆した後、(A)層を被覆した場合は、より粒度の小さ
い造粒物を得ることができる。また、本発明の腸溶性造
粒物は、(A)層、(B)層を交互に何層か被覆、形成
させ、多層造粒物としてもよい。
Regarding the coating of the granulated material with the layer (A) and the layer (B), either the layer (A) or the layer (B) may be coated first. When the (A) layer is coated first and then the (B) layer is coated, the gastric juice resistance is more excellent, and the working efficiency at the time of producing a granulated product is good. Conversely, when the layer (B) is coated first and then the layer (A) is coated, a granulated product having a smaller particle size can be obtained. The enteric granulated product of the present invention may be formed into a multilayer granulated product by alternately coating and forming several layers of the (A) layer and the (B) layer.

【0020】次に、上記被造粒物、(A)層、(B)層
を用いて本発明の腸溶性造粒物は、例えば、次のように
して製造することができる。すなわち、(A)層を先に
被覆する場合には、まず、被造粒物と賦形剤と小麦,大
豆,米,コラーゲン及びゼラチン由来の含水アルコール
可溶性蛋白質もしくはツェインの少なくとも1つとを混
合し、これに予め液状に溶融させた油脂を加えて保温し
ながら混合攪拌する。保温温度は、油脂の均一分散性、
被造粒物の熱変性防止の点で、好ましくは45℃以下、
更に好ましくは30〜45℃にする。
Next, the enteric granulated product of the present invention can be produced, for example, as follows using the above-mentioned granulated product, layer (A) and layer (B). That is, when coating the layer (A) first, first, the granulated material, excipient, wheat,
Hydrous alcohol derived from beans, rice, collagen and gelatin
Soluble protein or mixture of at least one bets zein, and mixed stirred while kept by addition of fat was melted beforehand liquid thereto. Insulation temperature is uniform dispersibility of fats and oils,
From the viewpoint of preventing thermal denaturation of the granulated material, preferably 45 ° C or less,
More preferably, the temperature is 30 to 45 ° C.

【0021】また、油脂の使用量は、(A)層全体重量
中、10〜30%とすることが望ましい。油脂が10%
未満であると、被造粒物表面を充分に油脂で被覆するこ
とが出来ず、長期保存性、耐胃液性悪くなる傾向にあ
る。逆に、30%を超えると、造粒時に滑り現象が生
じ、造粒しにくい傾向になる。また、賦形剤及び
麦,大豆,米,コラーゲン及びゼラチン由来の含水アル
コール可溶性蛋白質もしくはツェインの使用量は、適宜
設定すればよいが、油脂の均一分散性、被造粒物への油
脂被覆適性、造粒適性の点から(A)層全体重量中、賦
形剤は20〜50%、小麦,大豆,米,コラーゲン及び
ゼラチン由来の含水アルコール可溶性蛋白質もしくはツ
ェインは10〜50%とすることが望ましい。
The amount of the fat or oil is desirably 10 to 30% based on the total weight of the layer (A). 10% fat
By weight, can not be sufficiently coated with oil to be granulated surface, long term storage stability tends to gastric juice is deteriorated. On the other hand, if it exceeds 30%, a slip phenomenon occurs during granulation, and the granulation tends to be difficult. In addition, excipients, and small
Hydrous alcohol derived from wheat, soy, rice, collagen and gelatin
The amount of the coal-soluble protein or zein may be appropriately set, but from the viewpoint of uniform dispersibility of fats and oils, suitability for covering fats and oils on granules, and suitability for granulation, (A) the total weight of the layer, Is 20-50%, wheat, soy, rice, collagen and
Gelatin-derived hydroalcoholic soluble protein or tutu
The gain is desirably 10% to 50%.

【0022】次に、上記混合物を攪拌しながら、造粒装
置に供給し、造粒する。造粒装置としては、例えば、ス
クリーン付き造粒機、エクストルーダー等が挙げられ、
冷却手段を備えたものが造粒物を早く固形化できるので
好適である。
Next, the mixture is supplied to a granulator while stirring, and granulated. Examples of the granulator include a granulator with a screen, an extruder, and the like,
The one provided with a cooling means is preferable because the granulated material can be solidified quickly.

【0023】このようにして得られた(A)層被覆物
に、(B)層を噴霧・浸漬等によって被覆する。すなわ
ち、まず、小麦,大豆,米,コラーゲン及びゼラチン由
来の含水アルコール可溶性蛋白質もしくはツェインを含
水アルコール中に分散、溶解する。ここで用いる含水ア
ルコールは、アルコール濃度85〜95%程度が望まし
い。即ち、この範囲を逸脱すると、小麦,大豆,米,コ
ラーゲン及びゼラチン由来の含水アルコール可溶性蛋白
質もしくはツェインの含水アルコール中への均一分散、
溶解性が悪くなる傾向にある。
The (A) layer thus obtained is coated with the (B) layer by spraying or dipping. First, wheat, soy, rice, collagen and gelatin
The hydrous alcohol soluble protein or zein is dispersed and dissolved in the hydroalcohol. The hydrous alcohol used here preferably has an alcohol concentration of about 85 to 95%. In other words, if it deviates from this range, wheat, soybeans, rice,
Hydrous alcohol soluble protein from lagen and gelatin
Quality or zein uniformly dispersed in aqueous alcohol,
The solubility tends to be poor.

【0024】また、このとき、小麦,大豆,米,コラー
ゲン及びゼラチン由来の含水アルコール可溶性蛋白質も
しくはツェインと含水アルコールの比率は、小麦,大
豆,米,コラーゲン及びゼラチン由来の含水アルコール
可溶性蛋白質もしくはツェイン1に対し含水アルコール
6〜14にすることが均一溶解性、分散性の点で望まし
い。また、このとき、必要に応じて可塑剤を加える。
At this time, wheat, soybeans, rice,
Hydrous alcohol soluble protein derived from gen and gelatin
Or the ratio of zein to hydrous alcohol is wheat, large
Hydrous alcohol derived from beans, rice, collagen and gelatin
It is desirable to use 6 to 14 hydroalcohols with respect to the soluble protein or zein 1 from the viewpoint of uniform solubility and dispersibility. At this time, a plasticizer is added as needed.

【0025】次に、含水アルコールに分散溶解した溶液
を(A)層被覆物表面に施与し、乾燥する工程を繰返し
て(B)層を形成させる。施与する方法としては、噴
霧、浸漬等が挙げられる。例えば、噴霧する場合には、
レボリングパン等の転動機や、流動乾燥機、遠心流動造
粒乾燥機等を用いれば良い。
Next, the step of applying the solution dispersed and dissolved in the water-containing alcohol to the surface of the coating of the layer (A) and drying is repeated to form the layer (B). Examples of the method of application include spraying and dipping. For example, when spraying,
A rolling machine such as a revolving pan, a fluidized dryer, a centrifugal fluidized-bed granulator, or the like may be used.

【0026】このようにして得られた腸溶性造粒物の全
体重量中、小麦,大豆,米,コラーゲン及びゼラチン由
来の含水アルコール可溶性蛋白質もしくはツェインの少
なくとも1つは、好ましくは5〜50%、更に好ましく
は15〜30%含まれていることが望ましい。小麦,大
豆,米,コラーゲン及びゼラチン由来の含水アルコール
可溶性蛋白質もしくはツェインの少なくとも1つが5%
未満だと、耐胃液性が悪くなる傾向にあり、逆に、50
%を超えると、口中での食感が悪くなる傾向にある。そ
の中でも、(B)層に含有された小麦,大豆,米,コラ
ーゲン及びゼラチン由来の含水アルコール可溶性蛋白質
もしくはツェインの少なくとも1つは、腸溶性造粒物の
全体重量中3重量%以上含まれている。すなわち、3%
未満だと、耐胃液性が悪くなるのである。
In the total weight of the enteric granules thus obtained, wheat, soybeans, rice, collagen and gelatin
Low amount of native hydrous alcohol soluble protein or zein
At least one of them is preferably contained in an amount of preferably 5 to 50%, more preferably 15 to 30%. Wheat, large
Hydrous alcohol derived from beans, rice, collagen and gelatin
5% at least one of soluble protein or zein
If it is less than 50, the gastric juice resistance tends to be poor.
%, The texture in the mouth tends to deteriorate. Among them, wheat, soybean, rice, and kora contained in layer (B)
Hydrous alcohol soluble protein derived from gen and gelatin
Alternatively, at least one of the zeins is contained in an amount of 3% by weight or more based on the total weight of the enteric granules. That is, 3%
If it is less than this, gastric juice resistance becomes poor.

【0027】このようにして得られた腸溶性造粒物は、
そのまま経口摂取するようにしてもよく、あるいは粉末
ジュースやチューインガム、キャンディのセンターに利
用するようにしてもよい。また、香料、乳製品等を加え
て打錠した保健食品としてもよい。
The enteric granules thus obtained are
It may be taken orally as it is, or it may be used in powdered juice, chewing gum or candy centers. Also, it may be a health food that is compressed with a flavor, dairy product or the like.

【0028】以上のように、本発明の腸溶性造粒物は、
小麦,大豆,米,コラーゲン及びゼラチン由来の含水ア
ルコール可溶性蛋白質もしくはツェインの少なくとも1
つ、油脂及び賦形剤を含有する(A)層(長期保存性安
定化及び低pH域安定化層)と、小麦,大豆,米,コラ
ーゲン及びゼラチン由来の含水アルコール可溶性蛋白質
もしくはツェインの少なくとも1つを含有する(B)層
(低pH域安定化層)との2層により腸内生理活性物
被造粒物が被覆されているので、胃液中で造粒物が溶
解することなく、生理活性物質が、口から摂取した後に
胃液による影響を受けず、腸管内でその生理活性を発揮
することができる。また、長期保存性が安定である。
As described above, the enteric granulated product of the present invention comprises:
Hydrous water derived from wheat, soy, rice, collagen and gelatin
At least one of a soluble protein or zein
One, containing fats and excipients (A) layer and the (long-term storage stabilization and low pH range stabilizing layer), wheat, soybean, rice, Kola
Hydrous alcohol soluble protein derived from gen and gelatin
Or containing at least one of the zein layer (B) intestinal bioactive substances by two layers of the (low pH range stabilizing layer)
Because the granulated material is coated, the granulated material does not dissolve in gastric juice, and the physiologically active substance exerts its biological activity in the intestinal tract without being affected by gastric juice after ingestion from the mouth be able to. In addition, long-term storage stability is stable.

【0029】また、(B)層を形成するには、小麦,大
豆,米,コラーゲン及びゼラチン由来の含水アルコール
可溶性蛋白質もしくはツェインの少なくとも1つの施与
と乾燥とを繰り返し行うので、長い時間を要するが、
(A)層にも小麦,大豆,米,コラーゲン及びゼラチン
由来の含水アルコール可溶性蛋白質もしくはツェインの
少なくとも1つを混在させることにより、(B)層の形
成層を低減できるので、時間短縮ができ、かつ腸溶性効
果は高い。また、従来の造粒装置等を用いて連続的に製
造することができるので量産化することも可能である。
In order to form the layer (B), wheat, large
Hydrous alcohol derived from beans, rice, collagen and gelatin
It takes a long time to repeatedly apply and dry at least one soluble protein or zein ,
Wheat, soybeans, rice, collagen and gelatin in layer (A)
Of hydrous alcohol soluble protein or zein
By mixing at least one , the formation layer of the layer (B) can be reduced, so that the time can be reduced and the enteric effect is high. In addition, since it can be manufactured continuously using a conventional granulating apparatus or the like, it can be mass-produced.

【0030】次に、本発明を実施例を挙げて具体的に説
明する。 〔実施例1〕ラクトバチルス アシドフィラス(Lac
tobacillus acidophilus)の乾
燥乳酸菌体粉末(生菌数1010個/g)27重量部(以
下、部と記す)と、脱脂粉乳170部及びぶどう糖28
部の賦形剤と、ツェイン40部とを混合し、この混合物
に、40℃で溶融したパーム油脂75部を加えて攪拌し
た後、孔径0.8mmのスクリーンを設けた押出顆粒機
にて長さ1.5〜2mmの(A)層被覆物を得た。
Next, the present invention will be specifically described with reference to examples. Example 1 Lactobacillus acidophilus (Lac
27 parts by weight (hereinafter referred to as "parts") of dried lactic acid bacterial cell powder (viable cell count of 10 10 cells / g) of tobacillus acidophilus, 170 parts of skim milk powder and glucose 28
Parts of the excipient and 40 parts of zein, 75 parts of palm oil and fat melted at 40 ° C. were added to the mixture and stirred, and then the mixture was extruded with an extrusion granulator equipped with a screen having a pore diameter of 0.8 mm. A (A) layer coating having a thickness of 1.5 to 2 mm was obtained.

【0031】次に、ツェイン20部をエタノール水溶液
130部(エタノール100部,水30部)に少量ずつ
添加しながら分散溶解させ、次いで、グリセリン脂肪酸
エステル1部を添加し、被覆溶液とした。そして、遠心
造粒乾燥機を用い、ローター回転数120rpm,品温
25℃,ブロアー150L/minの条件下で上記
(A)層被覆物に上記被覆溶液を噴霧し、最終的にツェ
イン19%,油脂23%の腸溶性造粒物を得た。
Next, 20 parts of zein were dispersed and dissolved in 130 parts of an aqueous ethanol solution (100 parts of ethanol and 30 parts of water) little by little, and then 1 part of glycerin fatty acid ester was added to obtain a coating solution. Then, using a centrifugal granulation dryer, the above coating solution was sprayed on the above (A) layer coating under the conditions of a rotor rotation speed of 120 rpm, a product temperature of 25 ° C., and a blower of 150 L / min. An enteric granulated product of 23% fat was obtained.

【0032】〔比較例1〕実施例1において、被覆溶液
を用いない他は実施例1と同様にして造粒物を得た。
Comparative Example 1 A granulated product was obtained in the same manner as in Example 1 except that the coating solution was not used.

【0033】〔比較例2〕実施例1において、パーム油
脂を水に置換する他は実施例1と同様にして造粒物を得
た。
Comparative Example 2 A granulated product was obtained in the same manner as in Example 1 except that palm oil and fat were replaced with water.

【0034】上記実施例1,比較例1・2で得られた造
粒物1.00gを正秤し、人工胃液(0.12M−HC
l,NaCl2%,ペプシン0.32%,pH1.2)
50gに2時間浸漬し、次に、これを濾過し、得られた
残留物を滅菌水で洗浄後、直ちに人工腸液(0.1M−
KH2 PO4 ,0.1M−Na2 HPO4 ・2H2 O,
1:6,pH6.8)に37℃,1時間浸漬した。この
浸漬後の乳酸菌の残存生菌数を平板培養の常法で調べ
た。また、初期生菌数は、人工腸液のみ(人工胃液の浸
漬せず)の浸漬後の生菌数を調べた。更に、各造粒物を
20℃で4ケ月間保存した後の生菌数を調べた。その結
果を表1に示す。
1.00 g of the granules obtained in Example 1 and Comparative Examples 1 and 2 were weighed accurately, and were placed in an artificial gastric juice (0.12 M-HC).
1, NaCl 2%, pepsin 0.32%, pH 1.2)
It was immersed in 50 g for 2 hours, and then filtered, and the obtained residue was washed with sterile water and immediately thereafter, artificial intestinal fluid (0.1 M-
KH 2 PO 4, 0.1M-Na 2 HPO 4 · 2H 2 O,
1: 6, pH 6.8) at 37 ° C. for 1 hour. The number of remaining viable cells of the lactic acid bacteria after the immersion was examined by a conventional method of plate culture. The initial viable cell count was determined by examining the viable cell count after immersion of only artificial intestinal juice (without immersion of artificial gastric juice). Furthermore, the viable cell count after each granulated product was stored at 20 ° C. for 4 months was examined. Table 1 shows the results.

【0035】[0035]

【表1】 [Table 1]

【0036】上記の結果から、実施例の腸溶性造粒物は
耐胃液性に優れた造粒物であった。また、保存性も安定
であった。
From the above results, the enteric granules of Examples were granules having excellent gastric juice resistance. The storage stability was also stable.

【0037】〔実施例2〜5〕油脂使用量((A)層被
覆物全体重量中に占める重量%)を表2の割合にする他
は実施例1と同様にして造粒物を得た。得られた造粒物
の耐胃液性を実施例1と同様にして調べた。尚、油脂の
増減に伴い、脱脂粉乳量を調整した。以上の結果を表2
に示す。
[Examples 2 to 5] Granules were obtained in the same manner as in Example 1 except that the amount of fats and oils used (% by weight based on the total weight of the (A) layer coating) was changed to the ratio shown in Table 2. . The gastric juice resistance of the obtained granules was examined in the same manner as in Example 1. In addition, the amount of skim milk powder was adjusted according to the increase and decrease of the fats and oils. Table 2 shows the above results.
Shown in

【0038】[0038]

【表2】 [Table 2]

【0039】表2の結果から、油脂30%添加に於ても
生菌数は高く、造粒時に滑性現象が起こらず、造粒適性
が良好であった。
From the results shown in Table 2, the viable cell count was high even with the addition of 30% of fats and oils, no slip phenomenon occurred during granulation, and the granulation suitability was good.

【0040】〔実施例6〜8〕 実施例1のツェインを表3の様に含水アルコール可溶に
分画した大豆蛋白、小麦蛋白及びゼラチンに代える他は
実施例1と同様にして造粒物を調製し、生菌数を測定し
た。その結果を表3に示す。
[Examples 6 to 8] Granules in the same manner as in Example 1 except that zein of Example 1 was replaced with soybean protein, wheat protein and gelatin which were fractionated so as to be soluble in hydroalcohol as shown in Table 3. Was prepared, and the number of viable bacteria was measured. Table 3 shows the results.

【0041】[0041]

【表3】 [Table 3]

【0042】上記の結果から、大豆蛋白、小麦蛋白及び
ゼラチンを用いた腸溶性造粒物は、胃液耐性に優れた造
粒物であった。
From the above results, soy protein, wheat protein and
The enteric granules using gelatin were granules having excellent gastric juice resistance.

【0043】〔実施例9〜13〕実施例1のツェインの
含有量(造粒物全体重量中に占める重量%)を表4の様
に代える他は、実施例1と同様にして造粒物を調製し、
生菌数を測定した。以上の結果を表4にあわせて示す。
[Examples 9 to 13] Except that the content of zein (% by weight based on the total weight of the granulated product) of Example 1 was changed as shown in Table 4, the granulated product was prepared in the same manner as in Example 1. Is prepared,
The number of viable bacteria was measured. The above results are also shown in Table 4.

【0044】[0044]

【表4】 [Table 4]

【0045】表4の結果から、ツェイン含有量が15%
以上であると、特に、被造粒物が胃液耐性を発揮し良好
であった。
From the results shown in Table 4, the zein content was 15%.
Above, the granulated material exhibited gastric juice resistance and was particularly good.

【0046】〔実施例14〕実施例1の乾燥乳酸菌体末
を生菌数109 個/g含有するラクトバチルス カゼイ
(Lactobacillus casei)とストレ
プトコッカス サーモフィラス(Streptococ
cus thermophillus)とを併用した乾
燥乳酸菌体末に置換する他は実施例1と同様に行った。
その結果、残存生菌数は107 個/gで良好であった。
Example 14 Lactobacillus casei and Streptococcus thermophilus containing 10 9 viable cells / g of the dried lactic acid bacterial cell powder of Example 1
Cus thermophilus) in the same manner as in Example 1 except that the dried lactic acid bacteria powder was used in combination.
As a result, the residual viable cell count was favorable at 10 7 cells / g.

【0047】〔実施例15〕実施例1の乾燥乳酸菌体末
を生菌数109 個/g含有するビフィドバクテリウム
ロングム(Bifidobacterium long
um)の乾燥ビフィズス菌体末に置換する他は実施例1
と同様に行った。常法に従い、この生菌数の確認として
嫌気ジャーを用いて嫌気条件下で培養を行った。その結
果、残存生菌数は107 個/gで良好な結果が得られ
た。
[Example 15] Bifidobacterium containing 10 9 viable cells / g of the dried lactic acid bacteria powder of Example 1
Longum (Bifidobacterium long)
Example 1 except that the dried bifidobacterium powder of um) was replaced with the powder.
The same was done. According to a conventional method, cultivation was performed under anaerobic conditions using an anaerobic jar to confirm the viable cell count. As a result, a good result was obtained with a residual viable cell count of 10 7 cells / g.

【0048】〔実施例16〕実施例15の賦形剤をビフ
ィズス菌の増殖因子とされるオリゴ糖を使用し、次の通
りにする他は実施例15と同様に行った。すなわち、脱
脂粉乳150部,ぶどう糖18部,オリゴ糖30部の賦
形剤から成る混合物とした。得られた腸溶性造粒物の残
存生菌数は107 個/gと略同等で良好であった。
Example 16 The procedure of Example 15 was repeated, except that the excipient used in Example 15 was an oligosaccharide used as a growth factor for Bifidobacterium, and the following was carried out. That is, a mixture comprising excipients of 150 parts of skim milk powder, 18 parts of glucose, and 30 parts of oligosaccharide was used. The number of viable cells remaining in the obtained enteric granules was about 10 7 / g, which was good.

【0049】〔実施例17〕実施例1の被覆溶液をツェ
インとゼラチンを併用し、次の様にする他は実施例1と
同様に行った。ゼラチン3部を水30部に溶解し、エタ
ノール100部を加えた溶媒溶液にツェイン17部を少
量ずつ添加しながら分散溶解し、次いで糖アルコール2
部を添加したものを被覆溶液とした。得られた腸溶性造
粒物の残存生菌数は108 個/gと同等で良好であっ
た。
[Example 17] The coating solution of Example 1 was used in the same manner as in Example 1 except that zein and gelatin were used in combination, and the following was carried out. Dissolve 3 parts of gelatin in 30 parts of water, disperse and dissolve while adding 17 parts of zein little by little to a solvent solution to which 100 parts of ethanol is added.
A part of the solution was added. The number of viable cells remaining in the obtained enteric granules was as good as 10 8 cells / g.

【0050】〔実施例18〕ラクトバチルス アシドフ
ィラス(Lactobacillus acidoph
ilus)の乾燥乳酸菌体末(生菌数1010個/g)の
被造粒物にツェイン20部をエタノール水溶液130部
(エタノール100部,水30部)に分散溶解した被覆
溶液を遠心乾燥造粒機にて被覆乾燥した。次に、脱脂粉
乳60部,粉糖50部,ツェイン40部及び溶融したパ
ーム硬化油脂150部の混合物を該被覆乾燥物に回転釜
を用いて被覆し、腸溶性造粒物を得た。得られた腸溶性
造粒物は初期生菌数108 個/g,残存生菌数は108
個/gであり、本発明の構成要件を満たしていた。
Example 18 Lactobacillus acidophilus
A coating solution in which 20 parts of zein were dispersed and dissolved in 130 parts of an aqueous ethanol solution (100 parts of ethanol and 30 parts of water) was added to a granulated product of dried lactic acid bacteria powder (viable cell count: 10 10 cells / g) of Ilus) The coating was dried with a granulator. Next, a mixture of 60 parts of skim milk powder, 50 parts of powdered sugar, 40 parts of zein and 150 parts of melted palm oil and fat was coated on the coated dried product using a rotary kiln to obtain enteric granules. The resulting enteric granulated product had an initial viable cell count of 10 8 / g and a residual viable cell count of 10 8.
Pcs / g, which satisfied the constituent requirements of the present invention.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 35/74 A61K 35/74 A C12N 1/04 C12N 1/04 1/20 1/20 C (58)調査した分野(Int.Cl.7,DB名) A61K 9/38 A23L 1/00 A23L 1/28 A61K 9/14 A61K 9/20 A61K 35/74 C12N 1/04 C12N 1/20 ────────────────────────────────────────────────── ─── Continued on the front page (51) Int.Cl. 7 Identification code FI A61K 35/74 A61K 35/74 A C12N 1/04 C12N 1/04 1/20 1/20 C (58) Fields surveyed (Int. .Cl. 7 , DB name) A61K 9/38 A23L 1/00 A23L 1/28 A61K 9/14 A61K 9/20 A61K 35/74 C12N 1/04 C12N 1/20

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】被造粒物が下記(A)及び(B)に示され
る2層で被覆されてなる腸溶性造粒物であって、該被造
粒物が生理活性物質であり、かつ、(B)層に含有され
小麦,大豆,米,コラーゲン及びゼラチン由来の含水
アルコール可溶性蛋白質もしくはツェインの少なくとも
1つを、腸溶性造粒物全体重量中3重量%以上含有する
ことを特徴とする腸溶性造粒物。 (A)小麦,大豆,米,コラーゲン及びゼラチン由来の
含水アルコール可溶性蛋白質もしくはツェインの少なく
とも1つ、油脂及び賦形剤含有層。 (B)小麦,大豆,米,コラーゲン及びゼラチン由来の
含水アルコール可溶性蛋白質もしくはツェインの少なく
とも1つを含有してなる層。
1. A subjected to granulation is below (A) and enteric granules coated with two layers composed as shown (B), the 該被granulation
The granules are physiologically active substances, and the water contained in layer (B) is derived from wheat, soybeans, rice, collagen and gelatin
Alcohol soluble protein or zein
An enteric granulated product comprising one or more of 3% by weight or more based on the total weight of the enteric granulated product. (A) Derived from wheat, soy, rice, collagen and gelatin
Low in hydroalcohol soluble protein or zein
Both one fat and excipients containing organic layer. (B) from wheat, soy, rice, collagen and gelatin
Low in hydroalcohol soluble protein or zein
A layer containing both of them .
JP02186292A 1992-01-09 1992-01-09 Enteric granules Expired - Fee Related JP3187502B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP02186292A JP3187502B2 (en) 1992-01-09 1992-01-09 Enteric granules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02186292A JP3187502B2 (en) 1992-01-09 1992-01-09 Enteric granules

Publications (2)

Publication Number Publication Date
JPH05186335A JPH05186335A (en) 1993-07-27
JP3187502B2 true JP3187502B2 (en) 2001-07-11

Family

ID=12066932

Family Applications (1)

Application Number Title Priority Date Filing Date
JP02186292A Expired - Fee Related JP3187502B2 (en) 1992-01-09 1992-01-09 Enteric granules

Country Status (1)

Country Link
JP (1) JP3187502B2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11189666A (en) 1997-12-26 1999-07-13 Showa Sangyo Co Ltd Method for imparting water resistance to polysaccharide molded article
JP4147624B2 (en) * 1998-06-03 2008-09-10 日油株式会社 Method for producing powdery composition and powdery composition
DE19937361A1 (en) * 1999-08-12 2001-02-22 Merck Patent Gmbh Oral dosage form
JP4580542B2 (en) * 2000-05-17 2010-11-17 株式會社バイオニア Microorganism for treating obesity or diabetes and pharmaceutical composition containing the microorganism
US8785183B2 (en) * 2010-09-21 2014-07-22 Biogaia Ab Active plastic material in oil
KR101355003B1 (en) * 2010-11-02 2014-01-24 정명준 Lactic acid bacteria having multi coating layers and preparing method thereof
CN105815763B (en) * 2016-04-06 2018-10-02 福建省农业科学院农业工程技术研究所 A kind of Pleurotus eryngii perfume (or spice) silk and preparation method thereof

Also Published As

Publication number Publication date
JPH05186335A (en) 1993-07-27

Similar Documents

Publication Publication Date Title
US11400046B2 (en) Probiotic confection and lipid compositions
Martín et al. Microencapsulation of bacteria: A review of different technologies and their impact on the probiotic effects
US9480276B2 (en) Dry food product containing live probiotic
EP1514553B1 (en) Lactic acid bacteria powder double-coated using protein and polysaccharide and method preparing the same and a dosage form thereof
JP2968089B2 (en) Coating material and enteric-coated granules using the same
JP3187502B2 (en) Enteric granules
KR101707551B1 (en) Method for Preparing Chocolates Containing Viable Preparations of Lactic Acid Bacteria
Harel et al. Protection and delivery of probiotics for use in foods
JP3202053B2 (en) Enteric granules
KR102483912B1 (en) Method for producing soft capsule type functional health food
JPH05186337A (en) Enteric granule composed of multiple granules
JP6457963B2 (en) Large intestine delivery capsule formulation
EP1301081A1 (en) Cooked food products containing active yeast and method for preparing same
JPH06133735A (en) Enteric-coated lactobacillus granule
JPH0649654B2 (en) Highly stable enteric useful bacterial preparation and method for producing the same
JP2859216B2 (en) Method for producing granules containing useful intestinal bacteria having excellent acid resistance
US20240023568A1 (en) Fat encapsulated microbial cultures
JP2003189796A (en) Solid molded food having coated structure and method for producing the same
FR2811867A1 (en) Probiotic cooked food product with cooked pastry, filling(s) and/or casing(s), comprises live or active yeast present in pastry, filling and/or casing
CN117257845A (en) Method for targeted delivery of live probiotics
CN117256859A (en) Beverage containing living probiotics and multi-layer dripping pill used by same
JP3670988B2 (en) Biologically active substance-enclosed microparticles and method for producing the same
KR20240001347A (en) Vegetable marshmallow containing lactic acid bacteria and manufacturing method
Martın et al. ÔØ Å ÒÙ× Ö ÔØ

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees